Jonathan H. Kaufman - 14 May 2024 Form 4 Insider Report for LIPELLA PHARMACEUTICALS INC. (LIPO)

Role: President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors, Director, 10%+ Owner
Signature: /s/ Jonathan H. Kaufman
Issuer symbol: LIPO
Transactions as of: 14 May 2024
Transactions value $: $7,590
Form type: 4
Filing time: 15 May 2024, 16:39:19 UTC
Previous filing: 19 Mar 2024
Next filing: 27 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LIPO	Common Stock	Purchase	$7,590	+10,000	+1.13%	$0.7590	898,849	14 May 2024	Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Open market purchase by the reporting person of 10,000 shares of common stock, par value $0.0001 per share (the "Common Stock").
F2	Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on May 14, 2024 at prices ranging from $0.7552 to $0.76 per share, inclusive. The amount reflected has been rounded to 3 decimal points.
F3	The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range.

Remarks:

President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors